We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$155B
AUM Growth
+$5.59B
Cap. Flow
-$1.23B
Cap. Flow %
-0.8%
Top 10 Hldgs %
15.41%
Holding
3,924
New
119
Increased
2,245
Reduced
1,145
Closed
87

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$128M
2
AAL icon
American Airlines Group
AAL
+$99.2M
3
NAVI icon
Navient
NAVI
+$54.9M
4
ESS icon
Essex Property Trust
ESS
+$53.7M
5
AVGO icon
Broadcom
AVGO
+$47.2M

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.94%
3 Healthcare 13.29%
4 Industrials 10.85%
5 Energy 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQR icon
176
Equity Residential
EQR
$25.8B
$180M 0.12%
2,861,235
+26,090
+0.9% +$1.58M
KR icon
177
Kroger
KR
$36.7B
$180M 0.12%
7,277,760
-318,152
-4% -$7.41M
SYK icon
178
Stryker
SYK
$135B
$179M 0.12%
2,119,041
-13,181
-0.6% -$1.08M
CAH icon
179
Cardinal Health
CAH
$53.7B
$177M 0.11%
2,579,358
-75,593
-3% -$5.15M
CCI icon
180
Crown Castle
CCI
$34.6B
$176M 0.11%
2,377,630
-18,109
-0.8% -$1.36M
SRE icon
181
Sempra
SRE
$58.1B
$176M 0.11%
3,367,086
-31,092
-0.9% -$1.54M
PLD icon
182
Prologis
PLD
$136B
$176M 0.11%
4,282,872
+26,010
+0.6% +$1.07M
KMI icon
183
Kinder Morgan
KMI
$70.9B
$174M 0.11%
4,808,116
+43,285
+0.9% +$1.46M
TEL icon
184
TE Connectivity
TEL
$60B
$172M 0.11%
2,783,925
-31,114
-1% -$1.86M
TROW icon
185
T. Rowe Price
TROW
$25.5B
$170M 0.11%
2,019,546
+8,553
+0.4% +$698K
INTU icon
186
Intuit
INTU
$91.1B
$168M 0.11%
2,087,200
-16,842
-0.8% -$1.3M
MHFI
187
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$168M 0.11%
2,018,562
-54,246
-3% -$4.28M
CME icon
188
CME Group
CME
$95.4B
$167M 0.11%
2,354,688
-21,152
-0.9% -$1.49M
BEN icon
189
Franklin Resources
BEN
$16.8B
$167M 0.11%
2,881,598
-13,467
-0.5% -$737K
CB
190
DELISTED
CHUBB CORPORATION
CB
$167M 0.11%
1,808,154
-24,694
-1% -$2.27M
AMP icon
191
Ameriprise Financial
AMP
$47.8B
$166M 0.11%
1,385,205
-22,519
-2% -$2.52M
VRTX icon
192
Vertex Pharmaceuticals
VRTX
$123B
$165M 0.11%
1,740,295
-1,670
-0.1% -$117K
PPL
193
PPL Corp
PPL
$26.9B
$165M 0.11%
4,978,510
-42,989
-0.9% -$1.36M
MPC icon
194
Marathon Petroleum
MPC
$90.1B
$164M 0.11%
4,194,728
-334,970
-7% -$14.8M
REGN icon
195
Regeneron Pharmaceuticals
REGN
$72.9B
$164M 0.11%
579,518
+3,446
+0.6% +$1.02M
PCAR icon
196
PACCAR
PCAR
$70.5B
$163M 0.11%
3,900,060
-152,828
-4% -$6.53M
DOC icon
197
Healthpeak Properties
DOC
$15.5B
$163M 0.11%
4,327,193
+64,230
+2% +$2.42M
WELL icon
198
Welltower
WELL
$173B
$162M 0.1%
2,587,968
+128,649
+5% +$8.1M
PCG icon
199
PG&E
PCG
$39B
$162M 0.1%
3,376,092
+32,025
+1% +$1.45M
BDX icon
200
Becton Dickinson
BDX
$46.4B
$160M 0.1%
1,390,760
-5,697
-0.4% -$646K

Similar funds

Geode Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Geode Capital Management held 3,924 positions worth $155B, up 3.7% from $149B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2014 filing shows 119 new, 2,245 increased, 1,145 reduced and 87 closed positions. Its largest new stake was Navient: 3,319,977 shares worth $58.8M. The largest sale was Apple, an estimated $219M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Geode Capital Management's largest Q2 2014 buy was Navient: 3,319,977 shares worth $58.8M.
  • Geode Capital Management added most to Allergan plc in Q2 2014, an estimated $128M increase.
  • Geode Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $219M.
  • Geode Capital Management fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $103M.
  • Geode Capital Management's ten largest holdings make up 15% of its $155B portfolio in Q2 2014.
  • Geode Capital Management opened 119 new positions and closed 87 in Q2 2014.
  • Geode Capital Management's portfolio value rose 3.7% quarter-over-quarter to $155B.

Based on Geode Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.